Research use only · Not for human or veterinary use
Each vial ships with structural data and lot identifiers for the compound, plus a Certificate of Analysis documenting purity and identity. Ready for the bench. Synthesized via solid-phase peptide synthesis (SPPS), purified by reverse-phase HPLC, verified by mass spectrometry, and tested for sterility and endotoxin load. Every spec is documented on the signed Certificate of Analysis that ships with your vial.
BPC-157 is a 15-amino-acid sequence isolated from a partial fragment of a protein found in human gastric juice. In academic literature it is referred to as Body Protection Compound 157.
The compound has been the subject of preclinical investigation across rodent models, with published research examining its role in soft-tissue signaling cascades, gastric mucosal integrity, vascular pathways, and the nitric oxide system. Most studies cited in peer-reviewed databases originate from the Sikiric research group at the University of Zagreb.
The compound is most-cited alongside investigations of angiogenesis, growth factor signaling, and tissue regeneration pathways in animal models. It has not been approved by the FDA for any therapeutic indication and remains classified as a research compound.
Each vial ships with structural data and lot identifiers for the compound, plus a Certificate of Analysis documenting purity and identity. Ready for the bench. Synthesized via solid-phase peptide synthesis (SPPS), purified by reverse-phase HPLC, verified by mass spectrometry, and tested for sterility and endotoxin load. Every spec is documented on the signed Certificate of Analysis that ships with your vial.
BPC-157 is a 15-amino-acid sequence isolated from a partial fragment of a protein found in human gastric juice. In academic literature it is referred to as Body Protection Compound 157.
The compound has been the subject of preclinical investigation across rodent models, with published research examining its role in soft-tissue signaling cascades, gastric mucosal integrity, vascular pathways, and the nitric oxide system. Most studies cited in peer-reviewed databases originate from the Sikiric research group at the University of Zagreb.
The compound is most-cited alongside investigations of angiogenesis, growth factor signaling, and tissue regeneration pathways in animal models. It has not been approved by the FDA for any therapeutic indication and remains classified as a research compound.
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
PubMed · PubMed · 24920898Stable Gastric Pentadecapeptide BPC 157 in the Treatment of Colitis and Ischemia and Reperfusion of the Lower and Upper Extremities
PubMed · PubMed · 25869572At Revvd Research, quality comes first. Our peptides are produced using advanced manufacturing processes and verified through comprehensive testing protocols to deliver dependable results for research applications.
Produced
50mg / 10mg / 10mg per vial
10mg / vial
5mg / 5mg per vial
5mg / 5mg per vial
Featured Collection – Premium purity compounds crafted with consistency, precision, and quality in mind.
30-day money back · Free shipping over $150 · 2-day shipping
